Centre for Commercialization of Regenerative Medicine
The Centre for Commercialization of Regenerative Medicine is the name of two distinct public-private partnerships with operations in Canada and Australia.1)
Affiliations
Australia
In Australia, CCRM is funded and/or sponsored by Australian Red Cross Lifeblood, Cynata Therapeutics, Opyl, Regeneus, and Renerve.
Canada
In Canada, CCRM is funded and/or sponsored by 10x Genomics, Agilent, Amgen, Applikon, Aspect Biosystems, Athersys, AVROBIO, Axcelon Biopolymers, Axion Biosystems, Azenta Life Sciences, Beckman Coulter, BD, Bio-Techne, BioLegend, BioSpherix, Blood Centers of America, BlueRock Therapeutics, Cedarlane, CellCAN, CellScale, Compass Biomedical, Cytiva, Empirica Therapeutics (acquired in June 2020 by Century Therapeutics),2) Endogena Therapeutics, Eppendorf, ExCellThera, Feldan Therapeutics, FroggaBio, Hemostemix, Insception Lifebank, Interface Biologics, Invetech, iVexSol, Janssen (via BetaLogics), KisoJi Pharmaceuticals, MEDINET, Merck (via MilliporeSigma), Mesentech, Miltenyi Biotech, Morphocell Technologies, Nikon, Northern Therapeutics, Notch Therapeutics, Nucleus Biologics, Octane, OriGen, Pall, panCELLa, PDCI Market Access, PeproTech, Pfizer, Progenics Cord Blood Cryobank, RepliCel, Roche, Sartorius, Sernova, Sony, Spiber, STEMCELL Technologies, Steminent, SynGen, Terumo, Thermo Fisher Scientific, Tissue Regeneration Therapeutics, and VistaGen Therapeutics.3)
1)
About CCRM Australia. CCRM Australia. Retrieved March 8, 2022, from https://archive.ph/J64y9
2)
Yates, B. (2020, June 23). Century Therapeutics Announces Acquisition of Empirica Therapeutics. Business Wire; Berkshire Hathaway. https://archive.ph/Ou9gZ
3)
Industry Network. Centre for Commercialization of Regenerative Medicine (CCRM). Retrieved March 10, 2022, from https://web.archive.org/web/20210809081213/https://www.ccrm.ca/about-us-regenerative-medicine-cell-gene-therapy/